Drug Delivery Devices - GCC

GCC

Highlights

Revenue in the Drug Delivery Devices market market in the Gulf Cooperation Council (in Gulf Cooperation Council (GCC)) is anticipated to reach US$381.70m in 2024.
The revenue is projected to exhibit an annual growth rate (CAGR 2024-2029) of 6.32%, leading to a market volume of US$518.50m by 2029.
In a global context, the majority of revenue will be generated the United States, with a figure of US$15.01bn in 2024.
The GCC region is witnessing a significant shift towards advanced drug delivery devices, driven by increasing healthcare investments and a growing demand for innovative treatment solutions.

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Drug Delivery Devices Market in the GCC is witnessing moderate growth, influenced by factors such as advancements in technology, increasing healthcare needs, and rising investment in innovative medical solutions, which are enhancing patient care and treatment efficacy.

Customer preferences: Consumers in the GCC are showing a growing preference for personalized drug delivery devices that cater to their specific health needs, reflecting a shift towards individualized healthcare solutions. This trend is influenced by a rising awareness of chronic diseases and the desire for more effective management options. Additionally, the increasing adoption of smart technologies in drug delivery systems is attracting tech-savvy younger demographics, while cultural factors emphasize the importance of convenience and accessibility in healthcare, driving innovations in mobile and at-home delivery solutions.

Trends in the market: In the GCC, the Drug Delivery Devices Market is experiencing a notable shift towards personalized solutions, as consumers increasingly seek devices that address their unique health requirements. This trend correlates with the rising prevalence of chronic diseases, prompting a demand for innovative management tools. Furthermore, the integration of smart technology into drug delivery systems is appealing to younger, tech-savvy individuals, while cultural emphasis on convenience drives the development of mobile and at-home delivery options. Industry stakeholders must adapt to these evolving preferences to enhance patient engagement and improve health outcomes.

Local special circumstances: In the GCC, the Drug Delivery Devices Market is shaped by unique factors such as a rapidly growing population and an increasing prevalence of lifestyle-related diseases. Cultural norms emphasize a preference for discreet and efficient healthcare solutions, driving demand for portable and user-friendly devices. Additionally, regulatory frameworks in the region are evolving, with a focus on enhancing patient safety and efficacy of medical devices. This combination of cultural preferences and regulatory dynamics creates a distinct landscape, influencing innovation and adoption rates in drug delivery systems.

Underlying macroeconomic factors: The Drug Delivery Devices Market in the GCC is significantly influenced by macroeconomic factors such as rising healthcare expenditure, economic diversification efforts, and population demographics. As countries in the region invest in healthcare infrastructure to support their growing populations and combat lifestyle-related diseases, the demand for advanced drug delivery solutions increases. Additionally, government initiatives aimed at improving patient care and regulatory reforms enhance the market's appeal to manufacturers and investors. Global economic trends, including technological advancements and shifts toward personalized medicine, further drive innovation, leading to a competitive and rapidly evolving market landscape.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Explore more high-quality data on related topic

Medical technology industry - statistics & facts

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.